221 related articles for article (PubMed ID: 21140237)
1. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery.
de Campos-Lobato LF; Geisler DP; da Luz Moreira A; Stocchi L; Dietz D; Kalady MF
J Gastrointest Surg; 2011 Mar; 15(3):444-50. PubMed ID: 21140237
[TBL] [Abstract][Full Text] [Related]
2. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
3. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
4. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
[TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
6. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
7. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
[TBL] [Abstract][Full Text] [Related]
9. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.
You KY; Huang R; Zhang LN; Ding PR; Xiao WW; Qiu B; Chang H; Zeng ZF; Pan ZZ; Gao YH
J Cancer Res Clin Oncol; 2015 Apr; 141(4):719-28. PubMed ID: 25296560
[TBL] [Abstract][Full Text] [Related]
10. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
11. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
[TBL] [Abstract][Full Text] [Related]
13. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
[TBL] [Abstract][Full Text] [Related]
15. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
16. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.
Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1651-60. PubMed ID: 24880919
[TBL] [Abstract][Full Text] [Related]
17. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
19. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
